USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

PortfoliosPositionsRebalanceAnalyzeOptimize Suggest Industries

US Market Closed: Feb 9, 19:05 PM 2012

NYSE 8081.25 1.73 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and APRIF...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

APRIL GROUP ACT

Volatility

Matrix

Run Correlation

Diversification

Pay attention

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and APRIL GROUP ACT in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.0

Parameters

Time Period	1 Month [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Suggest

Salix Pharmaceuticals Ltd.

Profile

48.89

Intraday

One Month

^(0.33)

0.67%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	Day Low	48.80
Open	49.47	P/B Ratio	6.06
Market Cap	2.891B	Volume	222084
Sector	Healthcare	Last Close	49.22
Short Ratio	7.80	Last Traded	2/9/2012
Year High	50.28	Percent Change	0.67%
EBITDA	142.7M	Year Low	25.64
Absolute Change	0.33	Time	Not Applicable
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Employees	390
Day High	49.8084	Industry	Drugs - Generic
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable

APRIL GROUP ACT

Profile

0.0

Intraday

One Month

^0.00

0.00%

APRIF

PINK SHEET

APRIL GROUP ACT